Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium.
Public ClinicalTrials.gov record NCT03460704. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of 12 Months of Therapy With Inhaled Colistimethate Sodium in Subjects With Non-cystic Fibrosis Bronchiectasis Chronically Infected With P. Aeruginosa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the trial was to investigate the effect of the use of inhaled colistimethate sodium (CMS), administered twice a day (b.i.d.) via a specific nebulizer for 12 months, compared to placebo in subjects with non-cystic fibrosis bronchiectasis (NCFB) chronically infected with P. aeruginosa on the annualised frequency of pulmonary exacerbations.
Study identification
- NCT ID
- NCT03460704
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 287 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 29, 2018 (Actual)
- Primary completion
- Mar 15, 2022 (Actual)
- Completion
- Mar 15, 2022 (Actual)
- Last update posted
- Oct 15, 2026
2018 – 2022
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Zambon Investigative Site | Newport Beach | California | 92663 | — |
| Zambon Investigative Site | Palm Springs | California | 92262 | — |
| Zambon Investigative Site | Reseda | California | 91324 | — |
| Zambon investigative site | San Diego | California | 92103 | — |
| Zambon Investgative Site | San Diego | California | 92120-5241 | — |
| Zambon Investigative Site | Centennial | Colorado | 80112 | — |
| Zambon Investigative Site | Jacksonville | Florida | 32204 | — |
| Zambon Investigative Site | Kissimmee | Florida | 34741 | — |
| Zambon Investigative Site | Orlando | Florida | 32803 | — |
| Zambon investigative Site | St. Petersburg | Florida | 33704 | — |
| Zambon Investigative Site | St. Petersburg | Florida | 33707 | — |
| Zambon Investigative Site | Weston | Florida | 33331 | — |
| Zambon Investigative Site | Chicago | Illinois | 60637 | — |
| Zambon Investigative Site | Michigan City | Indiana | 46360 | — |
| Zambon Investigative Site | Louisville | Kentucky | 40202 | — |
| Zambon Investigative Site | Rochester | Minnesota | 55905 | — |
| Zambon Investigative Site | Chesterfield | Missouri | 63017-3625 | — |
| Zambon Investigative Site | Lebanon | New Hampshire | 03756-1000 | — |
| Zambon Investigative Site | New York | New York | 10016 | — |
| Zambon investigative site | Chapel Hill | North Carolina | 27514 | — |
| Zambon Investigative Site | Durham | North Carolina | 27705 | — |
| Zambon investigative site | Winston-Salem | North Carolina | 27265 | — |
| Zambon Investigative Site | Portland | Oregon | 97239 | — |
| Zambon Investigative Site | Tyler | Texas | 75708 | — |
| ZambonInvestigative Site | Abingdon | Virginia | 24210 | — |
| Zambon investigative site | Richmond | Virginia | 23219 | — |
| Zambon Investigative Site | Northwest | Washington | 20007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03460704, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03460704 live on ClinicalTrials.gov.